We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Ipilimumab, Nivolumab, Tocilizumab and Radiation in Pretreated Patients With Advanced Pancreatic Cancer (TRIPPLE-R)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT04258150
Recruitment Status : Terminated (primary endpoint was not met)
First Posted : February 6, 2020
Last Update Posted : March 31, 2022
Information provided by (Responsible Party):
Inna Chen, MD, Herlev Hospital

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : November 23, 2021
Actual Study Completion Date : November 23, 2021